PATENT CLAIM ANALYSIS

Application Number: 15933075
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "289000"]

Abstract:
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claim (Index 18):
A method of treating a human being in need of treatment with dextromethorphan, comprising administering a bupropion with a dextromethorphan to the human being for at least eight consecutive days, wherein the human being is an extensive metabolizer of dextromethorphan, wherein the bupropion is administered in an amount that results in a C avg  of the dextromethorphan on the eighth day of at least about 25 ng/mL, and wherein, on the eighth day that the bupropion and the dextromethorphan are co-administered, the AUC 0-12  of dextromethorphan is at least about 15 times the AUC 0-12  of dextromethorphan that would result from administering the same amount of the dextromethorphan without the bupropion for eight consecutive days.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.45455
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15691532', '15164767', '14997316', '15688660', '15695995']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.890325815303104
- 35 USC 102 Novelty (BERT): 0.6738736244012339
- Combined Prediction Score: 0.8686805962129169
- Mean Citation Score: 783.4113140000003
- Max Citation Score: 789.3872700000003
- Similarity Product: 653.3345003258713

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test